Minimal change nephropathy presenting in a patient with primary sclerosing cholangitis

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 3, 1997, Pages 267-269

  Fracchia, M ^a   Manganaro, M ^b   Poccardi, G ^a   Fera, A ^a   Galatola, G ^a  

^a MAURIZIANO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cell mediated immunity; Minimal change nephropathy; Primary sclerosing cholangitis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GLUCOCORTICOID; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HUMAN; KIDNEY DISEASE; LYMPHOCYTE COUNT; MALE; PERIPHERAL LYMPHOCYTE; PRIMARY SCLEROSING CHOLANGITIS; T LYMPHOCYTE;

ADULT; ANTI-INFLAMMATORY AGENTS; CHOLANGITIS, SCLEROSING; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MALE; NEPHROSIS, LIPOID; PREDNISONE;

EID: 0031472164     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Crippin JS, Lindor KD. Primary sclerosing cholangitis: Etiology and immunology. Eur J Gastroenterol Hepatol 1992;4:261-5.
2. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985;88:108-14.
3. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G and the Italian PSC Study Group. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicenter study. Eur J Gastroenterol Hepatol 1996:8:685-91.
4. Verresen L, Waer M, Verberckmoes R, Morias P, Michielsen P. Primary sclerosing cholangitis associated with membranous nephropathy. Ann Intern Med 1988;106:909-10.
5. Wilcox GM, Aretz HT, Roy MA, Roche JK. Glomerulonephritis associated with inflammatory bowel disease. Report of a patient with chronic ulcerative colitis, sclerosing cholangitis, and acute glomerulonephritis. Gastroenterology 1990;98:786-91.
6. Kheilralla JC, Arpin-Bott MP, Marcellin L, Krebs-Wurtz E, Imler M. Membranoproliferative glomerulopathy associated with primary sclerosing cholangitis. Rev Med Intern 1991;12:S208.
7. Romas E, Power AD, Machet D, Powell H, d'Apice AJF. Membranous glomerulonephritis associated with hepatitis C virus infection in an adolescent. Pathology 1994;26:399-402.
8. Lanier LL, Engleman EJ, Gatenby P, Babcock GF, Vamer NL, Herzenberg LA. Correlations of functional properties of human lymphoid cell subsets and surface marker phenotype using multiparameter analysis and flow cytometry. Immunol Rev 1984:74:143-8.
9. Lindor KD, Wiesner RH, Katzmann JA, LaRusso NF, Beaver SJ. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sei 1987;32:720-5.
10. Lindor KD, Wiesner RH, LaRusso NF, Homburger HA. Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 1987;7:884-8.
11. Shalhoub RJ. Pathogenesis of lipoid nephrosis. A disorder of T-cell function. Lancet 1974;2:556-60.
12. Ritz E. Pathogenesis of "idiopathic" nephrotic syndrome. N Engl J Med 1994;330:61-2.
13. Mandreoli M, Beltrandi E, Casadei-Maldini M, Mancini R, Zucchelli A, Zucchelli P. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy. Clin Nephrol 1992;37:177-88.